C166389Level 4
Atezolizumab/Carboplatin/Nab-paclitaxel Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of atezolizumab, carboplatin and nab-paclitaxel that may be used in the treatment of metastatic non-squamous non-small cell lung cancer (NSCLC).
**Synonyms:** - Atezolizumab/Carboplatin/Albumin-bound Paclitaxel - Atezolizumab/Carboplatin/Nab-paclitaxel - Atezolizumab/Carboplatin/Nanoparticle Albumin-bound Paclitaxel - Atezolizumab/Carboplatin/Paclitaxel Protein-bound - Carboplatin, nab-Paclitaxel, Atezolizumab - Tecentriq/Carboplatin/Abraxane
GET
/api/v1/systems/nci_thesaurus/nodes/C166389Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.